No information is present at this moment.
No information is present at this moment.
No information is present at this moment.
| Moderate to severe pain |
|---|
|
The excretion of tramadol is slowed in patients with kidney and/or liver function disorders. Extending the dosing interval should be considered carefully for these patients, according to their needs. Do not use if the creatinine clearance is < 10 ml/min)
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
No information is present at this moment.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Children have a higher risk of respiratory depression when using tramadol for all interventions / conditions where the airway could be obstructed in any way (FDA safety announcement 20-4-2017, Anderson et al 2017).
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.
| Natural opium alkaloids | ||
|---|---|---|
| N02AA03 | ||
| N02AA01 | ||
| N02AA05 | ||
| N02AA59 | ||
| Phenylpiperidine derivatives | ||
|---|---|---|
| N02AB03 | ||
| N02AB03 | ||
| N02AB02 | ||
| Diphenylpropylamine derivatives | ||
|---|---|---|
| N02AC06 | ||
| N02AC03 | ||
| Oripavine derivatives | ||
|---|---|---|
| N02AE01 | ||
| Morphinan derivatives | ||
|---|---|---|
| N02AF02 | ||
| Other opioids | ||
|---|---|---|
| N02AX06 | ||
| N02AX01 | ||
| N02AX02 | ||